Skip to content
Open access

Prevention of human papillomavirus (HPV): Croatian recommendations for HPV immunization among adolescents and adult populations

Sep 2026 · Liječnički vjesnik · 0 citations

TL;DR

There is no specific cure for HPV infection, but vaccination against HPV provides effective and long-term protection against infection with the most common types of HPV, including oncogenic types.

Abstract

One of the most common sexually transmitted infections is human papillomavirus (HPV) infection, which has great public health significance due to its epidemiological and clinical characteristics. In most people it resolves spontaneously without clinical symptoms or consequences, but in some infected people it may cause anogenital warts, while persistent infection with high-risk types may result in serious health complications and certain types of cancers. There is no specific cure for HPV infection, but vaccination against HPV provides effective and long-term protection against infection with the most common types of HPV, including oncogenic types. Therefore, HPV immunization is an important biomedical intervention for the prevention of HPV-related diseases. In accordance with international recommendations, national professional societies and institutions have developed Croatian recommendations for HPV vaccination for routine vaccination of adolescents and young people, and vaccination of adults based on medical indications.

Read PDF

Similar papers

Review Open access Sep 2026

Human Papillomavirus Vaccination as the Basis for Cervical Cancer Prevention: Current Status and Prospects in the Kyrgyz Republic

Human papillomavirus (HPV) is the primary etiological factor responsible for the development of cervical cancer and several other anogenital malignancies. According to the World Health Organization, more than 95% of cervical cancer cases are associated with persistent infection caused by high-risk HPV types. Currently,...

A. Amanbekov, Z. Kurmanalieva, C. Stakeeva et al. · 0 citations
Open access Sep 2026

Variation in HPV Vaccination Coverage Across the European Union

The current structural, cultural, and programmatic determinants of HPV vaccination differences across EU member states are investigated to investigate vaccine hesitancy, cervical cancer prevalence, immigration, single-dose regimen adoption, parent support, physician recommendation practices, and school-based vaccinatio...

L. Dupont, J. Jackson · 0 citations
Open access

Measuring the effects of the HPV vaccination program

Two- and three-dose vaccination schedules showed high effectiveness against HPV16/18 infections and significant cross-protection against HPV31 and HPV45, and three-dose vaccination was associated with lower viral loads in HPV16/18 infections, suggesting improved clearance.

M. Middeldorp · 0 citations
Open access Sep 2026

Role of HPV Vaccination in the Prevention of Cervical Cancer Distributed Throughout Bosnia and Herzegovina

Human papilloma virus (HPV) is an envelopeless, epitheliotropic virus that carries double-stranded, circular DNA that belongs to the Papillomaviridiae virus family. It represents one of the most commonly sexually transmitted diseases (STD) in the world with higher prevalence in low developed socio-economic countries. I...

Bijedić Armin, Abou El Ardat Mohammad, Aruković Haris et al. · 0 citations
Review 2026

Human Papillomavirus (HPV) Vaccination Among Adolescent Girls: A Narrative Review of Global Coverage, Determinants, and Strategies for Improvement

This narrative review synthesizes current global and regional evidence on HPV vaccine uptake among adolescent girls, examines the individual, sociocultural, and health-system determinants of uptake, and outlines evidence-supported strategies for narrowing persistent coverage gaps.

Karpagavalli Nageswaran, Shraddhadip Koitiya · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.